"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with "multi-bagger" returns in 2023. Year-to-date our "Multi-bagger" Portfolio is +15.4% versus only +3.4% for the S&P 500.

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some of them will bounce back with major - dare I say "multi-bagger" - returns - in 2023. The munKNEE "Multi-bagger" Portfolio consists of 12 stocks with market capitalizations between $100M and $399M (average of $189M).

Here's an update on how the various categories in the Portfolio, and their constituents, have performed year-to-date.

  1. American Cannabis MSO constituents:
    • Acreage (ACRDF/ACRHF): UP 18.3% YTD;
    • Ascend (AAWH): UP 10.8%% YTD;
    • Ayr (AYRWF): DOWN 4.1% YTD;
    • Columbia Care (CCHWF): DOWN 16.0% YTD;
    • Jushi (JUSHF): DOWN 5.4% YTD; and
    • Planet 13 (PLNHF): UP 27.5% YTD.
      • UP 1.0% YTD
    • For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) is DOWN 5.2% YTD
  2. Canadian Cannabis LP constituents:
    • Aurora (ACB): DOWN 3.4% YTD; and
    • Organigram (OGI): DOWN 3.8% YTD .
      • DOWN 3.6% YTD
    • For comparison purposes, the Global X Cannabis ETF (POTX) is DOWN 4.0% YTD
  3. Psychedelic Drug Stock constituents:
    • Cybin (CYBN): UP 72.4% YTD;
    • Mind Medicine (MNMD): UP 67.9% YTD; and
    • Seelos Therapeutics (SEEL): UP 3.1% YTD.
      • UP 54.8% YTD
    • For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) is DOWN 5.0% YTD
  4. Plant-Based Food Stock constituent:
    • Tattooed Chef (TTCF): UP 9.7% YTD.
      • UP 9.7% YTD
    • No comparable plant-based food stock ETFs

Grand Total: UP 15.4% YTD

The munKNEE "Multi-bagger" Portfolio continues to outperform our munKNEE "Rags-to-Riches" Portfoliowhich is only UP 7.5% YTD and the S&P 500 which is only UP 3.4%.


More By This Author:

Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
Only 2 Of 5 Cannabis Categories Have Advanced YTD
4 Of 5 Largest Canadian Cannabis LPs Have More Than A 50% Likelihood Of Going Bust

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample here).

STOCKS IN THIS ARTICLE

Comments